Skip to main content

Table 1 The Demographic Data, Genotypes, and Main Clinical and Biochemical Features of the Affected Individuals

From: Expanding the clinical spectrum of cytosolic phosphoenolpyruvate carboxykinase deficiency: novel PCK1 variants in four Arabian Gulf families

Family

Family 1

Family 2

Family 3

Family 4

Patient

1.1

1.2

(Proband)

1.3

2.1

(Proband)

2.2

3.1

(Proband)

4.1

(Proband)

Age

11 years

10 years

4 years

11 years

3 years

7 years

4 years

Age of onset

2 years

2.5 years

3 years

5 years

4 months

6 years

23 h

Gender

Female

Female

Male

Female

Female

Male

Male

Region

Oman

Oman

United Arab Emirates

Oman

PCK1 variant

c.961 + 1G > A; p.His322Glufs81*

Homozygous

c.574T > C; p.Cys192Arg

Homozygous

c.1268 C > T; p.Pro423Leu

Homozygous

Main clinical features

Asymptomatic

Fever, vomiting, encephalopathy, with lethargy, seizures, hepatomegaly, hyperreflexia, and hypertonia

Vomiting, encephalopathy, lethargy, and seizures

Recurrent vomiting

Recurrent vomiting, lethargy, and hyperreflexia

Recurrent vomiting,

recurrent URTI,

intermittent asthma, and

hepatomegaly

Encephalopathic with respiratory distress and seizures, lower limb hypertonia, and hyperreflexia

Main biochemical features

Hypoglycemia was reported once during gastroenteritis illness

Hypoglycemia, elevated CK, AST, ALT, and TCA metabolites

Hypoglycemia, mildly elevated lactate, and AST

Hypoglycemia, ketonuria, and mildly elevated lactate

Hypoglycemia, mildly elevated ALT, AST, lactate, and branched-chain amino acids

Hypoglycemia

Metabolic acidosis with high anion gap, and

high alanine

Hypoglycemia, elevated ammonia, and lactate levels

Outcome at last evaluation

Normal Development

Profound intellectual disability, autism, epileptic encephalopathy

Normal development

Normal development

Normal development

Normal development

Microcephaly, and developmental delay